• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION POWERFLEXPRO 8MM4CM 80; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION POWERFLEXPRO 8MM4CM 80; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number 4400804S
Medical Device Problem Code Burst Container or Vessel (1074)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/12/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A review of the manufacturing documentation associated with lot 82171682 presented no issues during the manufacturing process that can be related to the reported event.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event or Problem Description
As reported, an 8mm x 4cm x 80cm power flex pro percutaneous transluminal angioplasty balloon catheter was used for post-dilation however, it ruptured.Therefore, the device was removed intact (in one piece) from the patient¿s body and replaced with a non-cordis balloon catheter and the procedure was completed.There was no reported patient injury.The device was stored and handled as per the instruction for use (ifu).There were no damages noted to the packaging of the device prior to use.The device was prepped according to the ifu.There was no difficulty removing the product from the hoop and the protective balloon cover.There was no difficulty removing the stylet or any of the sterile packaging components.There were no kinks or other damages noted prior to inserting the product the product into the patient.The device was prepped normally (i.E.Maintain negative pressure).The same indeflator was used successfully with other devices.There was no resistance/friction while inserting the balloon through the rotating hemostatic valve and through the guide catheter.The target lesion was the common iliac artery (cia) which had ninety-nine percent (99%) stenosis.The lesion was moderately calcified.There was moderate vessel tortuosity.The device was not used for a chronic total occlusion (total occlusion >3 months).There was no difficulty advancing the balloon catheter through the vessel.There was no difficulty crossing the lesion.The catheter was never in an acute bend.The plunger was depressed into the indeflator when trying to inflate.The user was able to depress the plunger into the indeflator when trying to inflate.The balloon did not seem to ¿stick¿ to a stent.The device will not be returned as it was discarded due to suspicious infectious disease.Additional procedural details were requested but are unknown.
 
Additional Manufacturer Narrative
After further review of additional information received the following sections g4, g7, h2 and h6 have been updated accordingly an 8mm x 4cm x 80cm powerflex pro percutaneous transluminal angioplasty balloon catheter was used for post-dilation; however, it ruptured.There was no reported patient injury.The target lesion was the common iliac artery (cia) which had ninety-nine percent (99%) stenosis.The lesion was moderately calcified with moderate vessel tortuosity.The device was not used for a chronic total occlusion (total occlusion >3 months).The device was then replaced with a non-cordis balloon catheter and the procedure was completed.The device was stored and handled as per the instruction for use (ifu).There were no damages noted to the packaging of the device prior to use.The device was prepped normally (i.E.Maintain negative pressure) according to the ifu.There was no difficulty removing the product from the hoop, the protective balloon cover, the stylet or any of the sterile packaging components.There were no kinks or other damages noted prior to inserting the product into the patient.The same indeflator was used successfully with other devices.There was no resistance/friction while inserting the balloon through the rotating hemostatic valve or through the guide catheter.There was no difficulty advancing the balloon catheter through the vessel.There was no difficulty crossing the lesion.The catheter was never in an acute bend.The plunger was depressed into the indeflator when trying to inflate.The user was able to depress the plunger into the indeflator when trying to inflate.The balloon did not seem to ¿stick¿ to a stent.The device was removed intact (in one piece) from the patient¿s body additional procedural details were requested but are unknown.The product was not returned for analysis as it was discarded due to suspicious infectious disease.A product history record (phr) review of lot 82171682 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿balloon burst¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Vessel characteristics of 99 % stenosis with moderate calcification may have contributed to the reported event.Damage to balloon material may occur when attempting to cross a stenosed/calcified vessel.It is likely during this attempt to cross the damage occurred; however, without the return of the device for analysis it is difficult to draw a clinical conclusion between the device and the event reported.According to the safety information in the instructions for use ¿if resistance is met during manipulation, determine the cause of the resistance before proceeding.Balloon pressure should not exceed the rated burst pressure.The rated burst pressure is based on the results of in vitro testing.At least 99.9% of the balloons (with a 95% confidence), will not burst at or below their rated burst pressure.Use of a pressure monitoring device is recommended to prevent over pressurization.Use only the recommended balloon inflation medium.Never use air or any gaseous medium to inflate the balloon.Prior to angioplasty, the catheter should be examined to verify functionality and ensure that its size and shape are suitable for the specific procedure for which it is to be used.¿ neither the phr nor the information available suggests a design or manufacturing related cause for the reported event.Therefore, no corrective or preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERFLEXPRO 8MM4CM 80
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014
MDR Report Key9823457
Report Number9616099-2020-03556
Device Sequence Number14004592
Product Code LIT
UDI-Device Identifier20705032059814
UDI-Public20705032059814
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K112797
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 03/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2022
Device Model Number4400804S
Device Catalogue Number4400804S
Device Lot Number82171682
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/13/2020
Supplement Date Received by Manufacturer03/16/2020
Initial Report FDA Received Date03/12/2020
Supplement Report FDA Received Date03/24/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MUSTANG, BOSTON SCIENTIFIC BC
-
-